Journals / Üroonkoloji Bülteni / 2018 / Cilt: 17 - Sayı: 4

Genomic Evaluation of Testicular Germ Cell Tumors and its Role in Treatment Planning

Pages
138–142
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we briefly discussed the current information on some risk factors and genomic factors involved in the development of TGCTs

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The incidence of testicular germ cell tumors (TGCT) has significantly increased over the last 40 years and continues to increase among the young male population.
📊
Key Findings & Data:Although TGCTs respond well to chemotherapy, 20-30% of patients display classical chemotherapy resistance.
💡
Conclusion & Impact:In this review, we briefly discussed the current information on some risk factors and genomic factors involved in the development of TGCTs
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The incidence of testicular germ cell tumors (TGCT) has significantly increased over the last 40 years and continues to increase among the young male population. The geographical differences show that a combination of genetic and environmental factors play a role in the pathogenesis of TGCT. However, since the actual mechanisms involved in the development of this disease have still not been fully explained, studies at the genomic level have gained importance. Although TGCTs respond well to chemotherapy, 20-30% of patients display classical chemotherapy resistance. There exists a need for detailed investigation of the molecular mechanisms responsible for such resistance. In this review, we briefly discussed the current information on some risk factors and genomic factors involved in the development of TGCTs

🔖

Cite This Article

KİLİCCİOGLU, I., KONAÇ, E., SÖZEN, S. (2018). Genomic Evaluation of Testicular Germ Cell Tumors and its Role in Treatment Planning. Üroonkoloji Bülteni, Cilt: 17 - Sayı: 4, 138–142. https://ajindex.com/articles/334354

References (17)

  1. Rajpert-De Meyts E, McGlynn KA, Okamoto K, et al. Testicular germ cell tumours. Lancet 2016;387:1762-1774.
  2. Gilbert D, Rapley E, Shipley J. Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat Rev Cancer 2011;11:278-288.
  3. Sumat K, Rumana M, Parveen S. Clinicopathological Characteristics of Testicular Tumors. Clin Pathol 2017;1:000106. Facchini G, Rossetti S, Cavaliere C, et al. Exploring the molecular aspects associated with testicular germ cell tumors: a review. Oncotarget 2017;9:1365-1379.
  4. Horwich A, Shipley J, Huddart R, et al. Testicular germ-cell cancer. Lancet 2006;367:754-765.
  5. Rapley EA, Turnbull C, Al Olama AA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet 2009;41:807-810
  6. Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 2010;42:604-607.
  7. Znaor A, Lortet-Tieulent J, Jemal A, et al. International variations and trends in testicular cancer incidence and mortality. Eur Uro 2014;65:1095-1106.
  8. Pyle LC, Nathanson KL. Genetic changes associated with testicular cancer susceptibility. Semin Oncol 2016;43:575-581
  9. Rajpert-de Meyts E, Hoei-Hansen CE. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann N Y Acad Sci 2007;1120:168-180.
  10. Nathanson KL, Kanetsky PA, Hawes R, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005;77:1034-1043.
  11. Guo KM, Liu Y, Zhong YP, et al. Giant seminoma in an undescended testicle metastasizing to the neck and liver. Mol Clin Oncol 2016;4:983-985. Imaging of Urogenital Diseases: A Color Atlas; Editors: Olivetti Lucio, Grazioli Luigi, Publisher:
  12. Springer-Verlag Mailand, Copyright 2009 DOI 10.1007/978-88-470-1344-5.
  13. McGlynn KA, Cook MB. Etiologic factors in testicular germ-cell tumors. Future Oncol 2009;5:1389-1402.
  14. Litchfield K, Levy M, Huddart RA, et al. The genomic landscape of testicular germ cell tumours: from susceptibility to treatment. Nat Rev Urol 2016;13:409-419.
  15. Sandberg AA, Meloni AM, Suijkerbuijk RF. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J Urol 1996;155:1531-1556.
  16. Henegariu O, Vance GH, Heiber D, et al. Triple-color FISH analysis of 12p amplification in testicular germ-cell tumors using 12p bandspecific painting probes. J Mol Med (Berl) 1998;76:648-655.
  17. Boublikova L, Buchler T, Stary J, et al. Molecular biology of testicular germ cell tumors: